A Billion-Dollar Bet: Ranjan Pai's Bold Play for Troubled Byju's
The Great Edtech Reckoning: Manipal Group Steps Up, Eyes Troubled Byju's Empire
The Japan Breakthrough: How an Indian Biotech is Redefining Stem Cell Therapy Globally